Asthma is a chronic inflammatory disease of the airways in the lungs of children and adults.
The patient usually complains of shortness of breath, chest tightness and coughing with wheezing.
A diagnosis of asthma in young children is more likely if they have
symptom patterns, presence of risk factors for development of asthma and
therapeutic response to controller treatment.
Goals of treatment are effective symptom control with minimal or no
exacerbations, minimal or no nocturnal and daytime symptoms, no
limitations on activities, minimal or no need for reliever treatment,
and minimal adverse effects of medication.
Switching to a telemedicine-only strategy from face-to-face visits does not affect asthma control in children. Moreover, the strategy may actually increase show rates, according to a study presented at the recent ACAAI 2020 meeting.
A novel once-daily fixed-dose combination (FDC) of ICS-LABA* comprising mometasone furoate and indacaterol acetate (MF-IND) is superior over an ICS monotherapy of MF in improving lung function of patients with inadequately controlled asthma, the PALLADIUM study has shown — providing another once-daily FDC option for these patients.
In children with asthma, genotype testing identifies a specific genetic alteration associated with poor response to long-acting β2 agonist (LABA), as shown in the PACT trial. This information proves useful in prescribing appropriate medications and improving asthma control.
Children with gastro-oesophageal reflux disease (GERD) are at heightened risk of developing asthma, and those with asthma are prone to develop GERD, according to a study, which suggests that the two conditions have a bidirectional relationship.
Children with controlled asthma and severe asthma appear to have slightly better school performances than their healthy counterparts, a recent study suggests. However, those with uncontrolled conditions perform worse.
In the management of children hospitalized with severe asthma exacerbations, preservative-free albuterol formulations are safer for use in continuous nebulization compared with a benzalkonium chloride (BAC)-containing formulation, which is associated with longer treatment duration and additional respiratory support, as shown in a recent study.
Serum folate levels during pregnancy correlate with the child’s neurodevelopment at 2 years of age, particularly in terms of language development, a recent study has shown. Folate supplementation may be a valuable nutritional intervention to consider.
Fetoscopic laser ablation (FLP) is an effective treatment for twin-to-twin transfusion syndrome (TTTS) in monochorionic twin pregnancies, but it requires a tertiary neonatal facility and a highly specialized team in performing intervention therapies for the treatment of potential complications, according to a Singapore study.